Work

FG-3019, a human monoclonal antibody to connective tissue growth factor (CTGF), with gemcitabine/erlotinib (G/E) in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC).

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.4138

Authors: Vincent J. Picozzi, J. Marc Pipas, Albert Koong, Amato Giaccia, Nathan Bahary, Smitha S. Krishnamurthi, Charles D. Lopez, Peter J. O'Dwyer, Katharina Modelska, Mairead Carney, Heather Hernandez, James Chou, Tyson Lee, Ming Zhong, Seth Porter, Tom Neff, Frank Valone

Institutions: Virginia Mason Medical Center, Dartmouth–Hitchcock Medical Center, Stanford Medicine, Stanford University, University of Pittsburgh Medical Center, Case Western Reserve University, Oregon Health & Science University, Abramson Cancer Center, University of Pennsylvania, FibroGen (United States)

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2898233401

Cites:

Cited by: 12

Related to: 10